Join Asia’s Pharma & Biotech Festival in Singapore

Singapore, Dec 9, 2019 - (ACN Newswire) - The third edition of Phar-East is back once again in Singapore on March 31-April 1, 2020 at Resorts World Convention...

Captiva Verde Announces Mushroom Update to Agreement with Mexican Health Care Workers Union for...

Captiva Verde Land Corp. (CSE: PWR) (OTC: CPIVF) (the "Company" or "Captiva Verde"), is pleased to announce that further to its news release of...

TOT BIOPHARM Self-Developed Biological Drug TAB008 (Pusintin) Meets Primary Endpoint in Phase III Clinical...

TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK) is pleased to announce that the randomized Phase III clinical trial...

Holista攜手美國Path-Away(R)研發商GICC LLC,共同為全球市場研發鼻香膏

Holista將含Path-Away(R)成分的消毒液的分銷範圍擴展至東盟,英國和歐洲 Holista CollTech(ASX代碼:HCT)(以下簡稱“Holista”或本公司)今日宣布,它將在馬來西亞與合作夥伴一起共同研發和生產世界上第一款使用Path-Away®製成的鼻香膏。 Path-Away®是一種基於植物的不含酒精的活性成分,已被證明可以殺死所有先前已知的冠狀病毒,且不會對人造成傷害。 Path-Away®由Global Infection Control Consultants LLC(以下簡稱“ GICC LCC”)研發,該成分已被證明可殺死170多種病原體(包括病毒,細菌和真菌)。它可以殺死艾滋病毒以及極其頑固的結核分枝桿菌。馬來西亞衛生部批准其對H1N1病毒有效。 GICC LLC由其總裁兼首席研究科學家Arthur Martin博士創立,位於南卡羅來納州布盧夫頓。 共同為全球市場研發鼻香消毒膏 Martin博士和Holista創始人兼首席執行官Rajen Manicka博士共同宣布:“Covid-19疫情爆發後,兩家公司將擴大合作夥伴關係,並加快包含Path-Away®鼻香消毒膏的研發。” 兩家公司預計將於2020年第一季度共同申請鼻香消毒膏的全球專利,併計劃於2020年第三季度開始生產,然後在英國和歐洲的冬季開始前將其分銷至全球分銷。 鼻香膏將含有Path-Away®成分,它是由GICC LLC專有的一系列獨立工廠和工藝製成的。 Path-Away®會附著在病毒上,並通過抑制其吸收氨基酸(細胞的基本組成部分)的能力來削弱細胞壁。這迫使病毒細胞凝結在一起,並在此過程中幾乎立刻殺死自己。 Martin博士說:“空氣傳播的病毒只能通過眼睛,嘴巴和鼻子進入人體。口腔受唾液酶保護,眼睛會產生淚液,其中含有可以破壞病毒表面蛋白質的特定酶。但是,鼻子溫暖,潮濕且黑暗,尤其是在冬天。鼻腔通道富含脂肪和氨基酸,直接通向鼻竇,喉嚨,當然還有肺,因此最易受到病毒的侵害。” “我們很高興與Holista合作研發出相當於NatShield™消毒液的鼻香消毒膏,因為口罩過於鬆散,無法完全貼合面部,不能為鼻子提供全方位保護。這可能會使小液滴進入口腔或鼻子。由於Path-Away®是基於植物的且不含酒精,因此對鼻子無刺激性,有效期為六個小時。”他補充道。 手持消毒液最新進展;與菲律賓裝瓶商合作 由Holista研發的含有Path-Away®的手持式NatShield™消毒液目前在馬來西亞裝瓶,並在東盟的10個國家/地區銷售。當地藥房的存貨已用盡,Holista表示其已與菲律賓的3家裝瓶商合作來滿足訂單需求。 Holista CollTech首席執行官Rajen Manicka博士說:“鑑於對Covid-19的擔憂,Holista努力滿足馬來西亞和澳大利亞本地對消毒液的需求。” 分銷拓展至東盟外(包括英國和歐洲) GICC LLC已同意向Holista授予Path-Away®在東盟以外(包括英國和歐洲)的營銷和分銷權。 Holista將向英國和歐洲分銷NatShield™消毒液和鼻香消毒膏。 Holista還將與GICC LLC在北美市場合作,銷售NatShield™消毒液和鼻香消毒膏。 “我們也感謝Martin博士和GICC LCC授予Holista針對Path-Away®的歐洲分銷權。我們很高興與Martin博士的團隊針對Natshield™消毒液在北美市場進行合作。”他補充說。 淨化建築物和設施中氣流的設備 在資深工程師Martin博士的領導下,GICC LCC還開發了一套設備和過程,可幫助在機場,交通樞紐,醫院,學校和工廠等建築物中部署Path-Away®,以改善空氣質量。解決方案包括將含有Path-Away®的薄霧泵入空調和通風系統,以消滅此類封閉公共場所中存在的致命病原體。 PathAway®已在多個國家和市場領域使用了十多年,用以預防疾病和提高生產效率。 GICC LLC曾於2009年使用PathAway®在H1N1流感爆發期間為馬來西亞提供幫助,並在2003年的SARS爆發期間為新加坡提供了幫助。 Holista現將在中國大陸,澳門,香港和台灣地區以外的亞太地區獨家代理該技術。 資金更新 正如本月早些時候公司向澳大利亞證券交易提交的公告,自2020年初以來,該公司已利用資本控製配售協議(Acuity...

Cheney Mao – Chairman & CEO, Viva Biotech, China

Dr Cheney Mao, chairman and CEO of Viva Biotech, shares the extremely unique business model of the company, which started as a highly specialized...

China Biotech Services LY007 Cell Injection Obtained Clinical Trial Approval Letter

China Biotech Services Holdings Limited (HKG:8037) non-wholly-owned subsidiary Shanghai Longyao Biotechnology Co., Ltd., received an approval letter from the National Medical Products Administration for...

ALG Health Receives NIOSH Surgical Rating on Three Of Its American Made N95 Respirators

Per the CDC, NIOSH, and National Personal Protective Technology Laboratory Certified Equipment List, ALG Health is one of only three companies who manufacture their...

VIC Rewards and XcelTrip Bring Blockchain-enabled Vitality Packages to Consumers

CEO of XcelTrip, Mr. Gyanendra Khadka, and Dr. Richard Satur, CEO of VIC Rewards, are joining their platforms to challenge the Medical Tourism Marketspace....

Will Coronavirus (Covid-19) Weaken in Springtime in the Northern Hemisphere? Covid-19 Seems Overrepresented in...

A group of consultants at Azabu Insights Inc., a strategic consulting company in Azabu Juban Tokyo, have been analyzing data to understand the correlation...

Agilex Biolabs acquires leading biolab TetraQ for APAC Expansion Plans

Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced the acquisition of leading biolab TetraQ, based at...

Made-in-Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials

First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid tumours Made-in-Singapore cancer drug, ETC-159, has...

Avantor Named Best Bioprocessing Supplier in Single-Use Manufacturing at Asia-Pacific Bioprocessing Excellence Awards 2021

Avantor Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials...

NutraLife Bioscience, Inc. Receives License to Grow and Process Industrial Hemp

Coconut Creek, FL - (ACN Newswire) - via NEWMEDIAWIRE -- NutraLife Biosciences, Inc. ("the Company" or "NutraLife") (OTCQB: NLBS) has received two licenses from the Wisconsin Department...

AIM ImmunoTech joins with ChinaGoAbroad for Ampligen China Entry against COVID-19

AIM ImmunoTech (NYSE American: AIM, or the Company), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral...

Five-minute Covid test will reveal if vaccine still works

Identify from a drop of blood whether a person's Covid-19 vaccine is still valid, in 5 Minutes! Swiss high-tech company ZENUM has developed one of...

Tauriga Sciences, Inc. Approved by Alibaba Group to Operate Global Seller Account

Flagship Product Tauri-Gum(TM) Successfully Listed on Alibaba.com Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"), a revenue generating company that operates through the development,...

Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore...

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel technologies including the targeting of...

Agilex Biolabs and Endpoints News Present ‘How to Move Trials to Australia’ Webinar

Adelaide, AUS, July 22, 2020 - (ACN Newswire) - Agilex Biolabs, Australia's largest specialist bioanalytical laboratory for clinical trials, and Endpoints News launched a...

Great Potential in RA Therapeutic Market, Sinomab Announces Latest Progress of its Drug Candidate...

SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to...

Sino Biopharm Invests in Sinovac LS, A Leading COVID-19 Vaccine Company in China

Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Group"; HKEX: 1177) has announced the investment of US$515 million in Sinovac Life Sciences Co., Ltd. ("Sinovac...